Navigation Links
Solta Medical Reports Fourth Quarter and Full Year 2012 Results
Date:2/19/2013

per share

$0.03($0.00)$0.09$0.06GAAP weighted average shares outstanding used in calculating basic net income (loss) per share

68,636,72560,959,18964,437,42760,573,428GAAP weighted average shares outstanding used in calculating diluted net income (loss) per share

68,636,72562,044,55564,437,42760,573,428Adjustments for dilutive potential common stock

4,778,8911,806,4415,170,8813,555,057Weighted average shares outstanding used in calculating non-GAAP diluted net income (loss) per share

73,415,61663,850,99669,608,30864,128,485 Solta Medical, Inc. CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands of dollars, except share and per share data)(unaudited)December 31,December 31,20122011ASSETSCurrent assets:Cash and cash equivalents 

$38,097$17,417Accounts receivable

20,57013,282Inventories

16,61116,524Prepaid expenses and other current assets 

8,4768,626Total current assets 

83,75455,849Property and equipment, net 

6,4016,818Purchased intangible assets, net

42,42849,352Goodwill

96,62096,620Other assets 

520659Total assets 

$229,723$209,298LIABILITIES AND STOCKHOLDERS' EQUITYLiabilities:Accounts payable 

$7,283$5,767Accrued liabilities 

17,34316,126Current portion of contingent consideration liability

21,400—Current portion of deferred revenue 

3,9854,521Short-term borrowings

8,3457,441Customer deposits 

637610Total current liabilities 

58,99334,465Deferred revenue, net of current portion 

683824Term loan, net of current portion

18,06316,959Non-current tax liabilities

2,4782,975Contingent consideration liability

38,50027,800Other  liabilities 

89992Total liabilities 

119,61683,115Stockholders' equity:Common stock, $0.001 par
'/>"/>

SOURCE Solta Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Solta Medical to Report Fourth Quarter 2012 Results Release and Host Conference Call on February 19, 2013
2. Solta Medical to Present at the Leerink Swann Global Healthcare Conference in New York on February 14, 2013
3. Solta Medical to Acquire Sound Surgical Technologies
4. Solta Medical Reports Third Quarter Results
5. Solta Medical And BTL Industries Resolve Patent Dispute
6. Solta Medical to Present at the 32nd Annual Canaccord Growth Conference
7. Solta Medical, Inc. Closes Public Offering of Common Stock
8. Solta Medical, Inc. Prices $15 Million Public Offering of Common Stock
9. Solta Medical, Inc. Announces Proposed Public Offering of Common Stock
10. Solta Medical Reports Second Quarter Results
11. Solta Medical to Present at the JMP Securities Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 28, 2015 ... new research report with market overview, trends, ... forecast, porter analysis, recent developments, competitive scenario ... Global Industry Insight: Human Insulin Market Development ...      (Logo: http://photos.prnewswire.com/prnh/20150727/756778) Explore more ...
(Date:7/28/2015)...  Roche (SIX: RO, ROG; OTCQX: RHHBY) launched ... Chemistry (AACC) 2015 Clinical Lab Expo today by ... unique educational initiative that demonstrates how Roche is ... the laboratory. The new LabLeaders initiative ... and the people within them through insight from ...
(Date:7/28/2015)... LINCOLNSHIRE, Ill. , July 28, 2015 ... leverage business acumen on par with their levels of ... Clinical Chemistry (AACC) Annual Meeting & Clinical Lab Expo, ... Box™ to deliver a comprehensive and intuitive ecosystem that ... advances in four key areas, Sysmex aims to add ...
Breaking Medicine Technology:Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 2Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 3Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 4Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 5Roche introduces LabLeaders educational initiative to help redefine the value of the laboratory at AACC 2015 Clinical Lab Expo 2Roche introduces LabLeaders educational initiative to help redefine the value of the laboratory at AACC 2015 Clinical Lab Expo 3Roche introduces LabLeaders educational initiative to help redefine the value of the laboratory at AACC 2015 Clinical Lab Expo 4Sysmex Moves Beyond a Better Box 2Sysmex Moves Beyond a Better Box 3Sysmex Moves Beyond a Better Box 4
... DALLAS, Aug. 20 Access Pharmaceuticals, Inc.,(OTC ... the clinical,development plan of ProLindac, its novel DACH ... clinical trials to be initiated in,late 2007/ early ... patients, designed to optimize single agent dosing through ...
... Program with Second Phase 2a ... ... MedImmune, Inc. today,announced that it has initiated a multi-dose, Phase 2a ... with,mild, persistent asthma. The placebo-controlled, dose-escalation study is,designed to evaluate the ...
Cached Medicine Technology:Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac 2Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac 3Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac 4MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma 2
(Date:7/28/2015)... ... July 28, 2015 , ... ADLINK Technology, a leading ... devices that enable the Internet of Things (IoT), announced its new medical panel ... provide exceptional computing power and multitasking capabilities. The MLC 4-21 is completely fanless, ...
(Date:7/28/2015)... ... July 28, 2015 , ... OrthAlign, Inc., ... its ORTHALIGN PLUS® system, a palm-sized, single-use navigation device for Total Hip Arthroplasty ... precision with practicality in a revolutionary way for Total Knee Arthroplasty surgeries and ...
(Date:7/28/2015)... ... July 28, 2015 , ... On July 16th ... to schedule the hearing of proposed bills and laws revolving the implementation of a ... to date. Some vigilante ministers are continuing to hand out clean needles to drug ...
(Date:7/28/2015)... ... July 28, 2015 , ... BiologicsMD, Inc. , a ... the treatment of bone disorders and conditions of hair loss, announced that the ... of Collagen Binding-Domain and Parathyroid Hormone". The issued patent claims methods of use ...
(Date:7/28/2015)... ... ... Fertility specialist Dr. Lisa Hasty of Atlanta Center for Reproductive ... Atlanta Magazine's annual Top Doctors issue, Dr. Hasty has been recognized for the fifth ... metro area as one of the most respected doctors in Reproductive Endocrinology. , “I’m ...
Breaking Medicine News(10 mins):Health News:ADLINK Launches High Performance, Fully-Sealed Medical-Grade Panel PC 2Health News:ADLINK Launches High Performance, Fully-Sealed Medical-Grade Panel PC 3Health News:OrthAlign, Inc. Announces U.S. Commercial Launch of ORTHALIGN PLUS®, the most complete handheld navigation device for use in Total Hip Arthroplasty Surgery 2Health News:OrthAlign, Inc. Announces U.S. Commercial Launch of ORTHALIGN PLUS®, the most complete handheld navigation device for use in Total Hip Arthroplasty Surgery 3Health News:Needle Exchange Programs Are Delayed in Legislation, West Palm Beach Drug Rehab Comments 2Health News:Needle Exchange Programs Are Delayed in Legislation, West Palm Beach Drug Rehab Comments 3Health News:BiologicsMD, Inc. Announces Additional US Patent Issuance Covering Company’s Pipeline of Targeted Therapies 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 3
... shorts in football prints and innerwear with net inserts ... lingerie designers are experimenting with.,Overall, the trend in lingerie ... with a hint of romance. The seductive undergarments require ... being tried with embroidery. The garments aren't so opulent, ...
... 7,000 cancer tumour samples for researchers all over the world ... the world over are hailing this step as a major ... truly international. ,"Cancer is not just one disease, ... misbehaving. Since it is multiple diseases, you have to have ...
... death has been reported in Egypt, the most populous North ... woman //, indeed died as a consequence of the highly ... from Nawa village in Qalyubiya, some 40 km north of ... she had been treated for flu-like symptoms, the health ministry ...
... the avian influenza H5N1 virus is receiving samples from across ... arrive each week, packed in ice boxes. // These samples ... chicken deaths and from routine surveillance sites. , ... Animal Disease Laboratory in Bhopal, is running out of space ...
... in kidney transplant recipients can be used in treatment ... 40 years ago, is still used to prevent the ... ,In around the 1960s, Roy Calne showed that ... this finding, a combination of azathioprine and corticosteroids were ...
... the direction of development of prosthetic limbs researchers at University ... by alcohol and hydrogen. // ,As it appears ... than the body's own. ,Two types of ... Institute at the University of Texas in Dallas, working with ...
Cached Medicine News:Health News:Romantic and discreet trends in lingerie 2Health News:Azathioprine Can Soon Revolutionize Eczema Treatment 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: